Dioseve Inc

Developer of iPS cell-derived egg production technology for infertility treatment

placeBunkyo, Tokyo, Japan calendar_todayFounded 2021 groups6 employees language dioseve.com

Investor mix

7 investors on record; lead investors include Spiral Capital, Archetype Ventures.

Investor typeCountShare
Venture capital457%
Private equity114%
Other / undisclosed229%
Coming soon